Outcome After Treatment of Pulmonary Aspergilloma
This trial is active, not recruiting.
|Condition||pulmonary fungal diseases|
|Sponsor||University Hospital, Gasthuisberg|
|Start date||October 2013|
|End date||April 2014|
|Trial size||100 participants|
|Trial identifier||NCT01958710, ASPERLEU|
Retrospective analysis of surgery and/or bronchial embolisation for pulmonary aspergilloma.
(preoperative) embolisation of the bronchial circulation
Any surgically treated patient with a functional lung resection (at least wedge resection)
survival after treatment
time frame: 10 years
post treatment survival
time frame: 90 days
Male or female participants from 1 year up to 89 years old.
Inclusion Criteria: - Histological proven Aspergilloma of the lung Exclusion Criteria: - Treatment limited to the use of systemic antifungal agents
|Official title||Outcome After Surgical Treatment or Bronchial Embolisation in Aspergilloma of the Lung: a Single Center Experience.|
|Principal investigator||Herbert Decaluwé, MD|
|Description||A retrospective chart analysis, based on the search results from a thoracic surgery database and an interventional radiology database. Outcome analysis of all surgically treated patients for a confirmed invasive aspergilloma. Comparisson with (preoperative) embolisation of the bronchial circulation.|
Call for more information